POLISCOPE
Back to feed
SB 1728FLORIDA · STATEWIDESession 2026dead

Proposed Licensing and Oversight for Medical Spas (SB 1728)

Original title: Licensure of Medical Spas

March 13, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The bill would have established a new regulatory framework for s, requiring them to designate a licensed health care professional as a '' and report serious patient s to the Board of Pharmacy.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medical spas

These facilities would have been required to obtain state licensure, undergo inspections, and comply with new drug storage and reporting requirements.

Board of Pharmacy

The board would have been tasked with creating a licensing database, conducting inspections, and enforcing new regulations for medical spas.

What changed

Last recorded activity March 13, 2026.

What's next

Introduced.

Background

  • Medical spas have grown rapidly in popularity, often operating in a regulatory gray area between traditional medical offices and retail cosmetic businesses. context

Summary

This bill would have required s that handle prescription medications to obtain a state license and comply with new safety, storage, and reporting standards. It aimed to increase regulatory oversight of cosmetic and wellness facilities that administer drugs like botulinum toxin or weight-loss medications.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What is a 'responsible person' under this bill?
A is a licensed health care provider with supervising authority at a who is responsible for ensuring the facility complies with state regulations.
What would have happened if a medical spa failed to get a license?
Failure to obtain a license or comply with the act could have resulted in disciplinary actions, including fines, suspension, or revocation of the license.
Did this bill pass?
No, the bill died in the Health Policy committee on March 13, 2026.

Why It Matters

The bill would have established a new regulatory framework for s, requiring them to designate a licensed health care professional as a '' and report serious patient s to the Board of Pharmacy.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Expansion of Pharmacy Board Oversight

The bill represented an attempt to bring cosmetic medical facilities under the regulatory umbrella of the Board of Pharmacy, treating them as 'dispensers' of medication.

Connected Entities

Sources

Open source document

openstates.org

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record